Current Size: 100%
Survival statistics
Cancer | Years | Method | Sex | Age | Survived | Net survival | 95% lower | 95% upper |
---|---|---|---|---|---|---|---|---|
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | 1.00 years | 77.4% | 77.1% | 77.7% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | 5.00 years | 62.4% | 62.0% | 62.8% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | 10.00 years | 58.5% | 57.9% | 59.2% |
All ex C44 | 2010-2014 | hybrid | Male | 15-99 | 1.00 years | 76.8% | 76.4% | 77.2% |
All ex C44 | 2010-2014 | hybrid | Male | 15-99 | 5.00 years | 62.4% | 61.9% | 63.0% |
All ex C44 | 2010-2014 | hybrid | Male | 15-99 | 10.00 years | 59.1% | 58.1% | 60.2% |
All ex C44 | 2010-2014 | hybrid | Female | 15-99 | 1.00 years | 78.1% | 77.7% | 78.5% |
All ex C44 | 2010-2014 | hybrid | Female | 15-99 | 5.00 years | 62.4% | 61.8% | 62.9% |
All ex C44 | 2010-2014 | hybrid | Female | 15-99 | 10.00 years | 57.9% | 57.1% | 58.7% |